Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Redx Pharma patents tyrosine-protein kinase BTK inhibitors

April 11, 2017

Assembly Biosciences, IURTC present HBV core protein modulators

April 10, 2017

Sunshine Lake Pharma, Calitor Sciences patent JAK, FLT-3 and Aurora kinase inhibitors

April 10, 2017

Merck KGaA discloses new IRAK-1/4 inhibitors

April 10, 2017

NSTDA patents dihydrofolate reductase inhibitors

April 10, 2017

Janssen identifies novel FGFR inhibitors

April 10, 2017

Indiana University Research and Technology, Assembly Biosciences present HBV core protein modulators

April 7, 2017

GlaxoSmithKline divulges novel anti-HIV compounds

April 7, 2017

Zhejiang Bossan Pharmaceutical describes new EGFR inhibitors

April 7, 2017

XW Laboratories patents gamma-hydroxybutyric acid prodrugs

April 7, 2017

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...